Anas Barbariae

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Anas Barbariae
Generic name: ANAS BARBARIAE
Manufacturer: OHM PHARMA INC.
Product type: HUMAN OTC DRUG
SPL set ID: 4e4335a5-87ee-4fb3-b7ae-8753a5b040c8
SPL ID: d450adc7-289b-63b2-e053-2a95a90afca1
Version: 3
Effective date: 2021-12-29
Source export date: 2026-11-06
Source partition: 10
Source file: https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-11-06/b0d9ca61dc485ebaf55e14a76d7d677668e40ef1e1978cdbcc4d73d58eba0b99/drug-label-0010-of-0014.json.zip
Source manifest SHA-256: 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run: 20261108T063105Z
Imported at: 2026-11-08 07:49:57

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 9 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		Anas Barbariae	openfda.brand_name
generic name		ANAS BARBARIAE	openfda.generic_name
manufacturer name		OHM PHARMA INC.	openfda.manufacturer_name
ndc	package	66096-784-01	openfda.package_ndc
ndc	product	66096-784	openfda.product_ndc
ndc11	package	66096078401	derived:openfda.package_ndc
spl id		d450adc7-289b-63b2-e053-2a95a90afca1	id
spl set id		4e4335a5-87ee-4fb3-b7ae-8753a5b040c8	set_id
unii		RN2HC612GY	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS: Keep out of reach of children. If pregnant or breast-feeding, ask a health care professional before use. Stop use and ask a health care professional if symptoms persist for more than 3 days or worsen. Keep out of reach of children.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.